Krystal Biotech, Inc. KRYS EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s EV / sales?
- Krystal Biotech, Inc. (KRYS) reported EV / sales of 16.9× in Q1 2026.
- How has Krystal Biotech, Inc.'s EV / sales changed year-over-year?
- Krystal Biotech, Inc.'s EV / sales increased by 15.2% year-over-year, from 14.7× to 16.9×.
- What is the long-term trend for Krystal Biotech, Inc.'s EV / sales?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s EV / sales has grown at a -47.5% compound annual growth rate (CAGR), from 62× to 17.1×.
- What does EV / sales mean?
- What the whole business costs relative to its annual sales.
- How do you interpret EV / sales?
- A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
- How does EV / sales compare across companies?
- Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.